Definium Therapeutics, Inc. (DFTX)
38.68
+0.83
(+2.19%)
USD |
NASDAQ |
Sep 17, 16:00
38.71
+0.03
(+0.08%)
After-Hours: 20:00
Definium Therapeutics Price : 38.68 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 38.86 | 39.78 | 38.02 | 38.68 | 1.730M |
| Sep 16, 2026 | 36.99 | 38.92 | 36.70 | 37.85 | 2.070M |
| Sep 15, 2026 | 40.44 | 40.44 | 36.78 | 36.82 | 4.527M |
| Sep 14, 2026 | 43.53 | 43.77 | 39.50 | 40.25 | 7.287M |
| Sep 11, 2026 | 37.73 | 39.37 | 37.73 | 38.89 | 1.754M |
| Sep 10, 2026 | 37.65 | 38.19 | 37.17 | 37.73 | 1.404M |
| Sep 09, 2026 | 37.82 | 38.93 | 37.68 | 37.99 | 1.285M |
| Sep 08, 2026 | 38.00 | 39.26 | 37.70 | 38.23 | 1.494M |
| Sep 04, 2026 | 37.94 | 38.54 | 37.38 | 38.09 | 1.129M |
| Sep 03, 2026 | 38.94 | 39.00 | 37.32 | 38.00 | 1.530M |
| Sep 02, 2026 | 38.50 | 40.06 | 38.10 | 38.90 | 1.429M |
| Sep 01, 2026 | 39.38 | 40.00 | 38.15 | 38.50 | 1.573M |
| Aug 31, 2026 | 40.61 | 41.34 | 39.16 | 39.72 | 2.693M |
| Aug 28, 2026 | 43.18 | 43.38 | 40.85 | 40.98 | 1.803M |
| Aug 27, 2026 | 44.18 | 44.97 | 43.33 | 43.82 | 1.417M |
| Aug 26, 2026 | 44.73 | 45.04 | 43.35 | 43.77 | 1.599M |
| Aug 25, 2026 | 43.97 | 45.31 | 43.62 | 44.81 | 1.271M |
| Aug 24, 2026 | 44.46 | 44.46 | 41.25 | 43.27 | 1.727M |
| Aug 21, 2026 | 45.89 | 46.57 | 44.80 | 44.91 | 1.355M |
| Aug 20, 2026 | 45.11 | 45.59 | 44.20 | 45.40 | 1.662M |
| Aug 19, 2026 | 47.00 | 47.29 | 44.59 | 45.82 | 1.748M |
| Aug 18, 2026 | 45.34 | 46.37 | 44.19 | 46.18 | 2.009M |
| Aug 17, 2026 | 42.20 | 45.32 | 42.04 | 45.26 | 2.278M |
| Aug 14, 2026 | 43.00 | 43.74 | 42.01 | 42.63 | 1.709M |
| Aug 13, 2026 | 44.00 | 45.11 | 42.91 | 43.90 | 2.664M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.14 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Arvinas, Inc. | 8.31 |
| Fulcrum Therapeutics, Inc. | 3.77 |
Price Related Metrics
| PEG Ratio | -0.0834 |
| Price to Book Value | 5.657 |
| Earnings Yield | -8.89% |
| Market Cap | 5.197B |
| PEGY Ratio | -0.0834 |